The TRUST study is a randomized, controlled multicenter study to evaluate the management of gout by comparing two commonly used treatment strategies for gout (TTT vs TTASx) to determine the most beneficial for a patient-centered gout outcomes, as well as relevant cardiovascular-metabolic-renal endpoints.
Gout
The TRUST study is a randomized, controlled multicenter study to evaluate the management of gout by comparing two commonly used treatment strategies for gout (TTT vs TTASx) to determine the most beneficial for a patient-centered gout outcomes, as well as relevant cardiovascular-metabolic-renal endpoints.
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
-
The University of Alabama at Birmingham, South Birmingham, Alabama, United States, 35233
UCLA Health, Santa Monica, California, United States, 90404
Massachusetts General Hospital, Boston, Massachusetts, United States, 02114
Brigham and Women's Hospital (BWH), Boston, Massachusetts, United States, 02115
Boston Medical Center (BMC), Boston, Massachusetts, United States, 02119
NYU Langone, NY, New York, United States, 10010
West Virginia University (Including Mobile Clinical Trials Unit), Morgantown, West Virginia, United States, 26506
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 90 Years
ALL
No
Massachusetts General Hospital,
Hyon K Choi, MD, PhD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital
2028-10-31